Picrocrocin, a monoterpene glycoside precursor of safranal, is a natural product found in the spice saffron, which comes from the crocus flower. Picrocrocin is a degradation product of the carotenoid zeaxanthin. Picrocrocin exhibits growth inhibitory effects against SKMEL- 2 human malignant melanoma cells by targeting JAK/ STAT5 signaling pathway, cell cycle arrest and mitochondrial mediated apoptosis.
Physicochemical Properties
| Molecular Formula | C16H26O7 |
| Molecular Weight | 330.3734 |
| Exact Mass | 330.168 |
| Elemental Analysis | C, 58.17; H, 7.93; O, 33.90 |
| CAS # | 138-55-6 |
| PubChem CID | 130796 |
| Appearance | White to off-white solid powder |
| Density | 1.31g/cm3 |
| Boiling Point | 520.4ºC at 760mmHg |
| Melting Point | 196 ºC (ethyl acetate ) |
| Flash Point | 187.1ºC |
| Vapour Pressure | 5.27E-13mmHg at 25°C |
| Index of Refraction | 1.561 |
| LogP | -0.5 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 4 |
| Heavy Atom Count | 23 |
| Complexity | 473 |
| Defined Atom Stereocenter Count | 6 |
| SMILES | O([C@@]1([H])[C@@]([H])([C@]([H])([C@@]([H])([C@@]([H])(C([H])([H])O[H])O1)O[H])O[H])O[H])[C@]1([H])C([H])([H])C(C([H])([H])[H])=C(C([H])=O)C(C([H])([H])[H])(C([H])([H])[H])C1([H])[H] |
| InChi Key | WMHJCSAICLADIN-WYWSWGBSSA-N |
| InChi Code | InChI=1S/C16H26O7/c1-8-4-9(5-16(2,3)10(8)6-17)22-15-14(21)13(20)12(19)11(7-18)23-15/h6,9,11-15,18-21H,4-5,7H2,1-3H3/t9-,11-,12-,13+,14-,15-/m1/s1 |
| Chemical Name | (4R)-2,6,6-trimethyl-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycyclohexene-1-carbaldehyde |
| Synonyms | Picrocrocin; Picrocrocine; Saffron-bitter; |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: This product requires protection from light (avoid light exposure) during transportation and storage. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | SK-MEL-2 melanoma cells are inhibited in their ability to proliferate by picrocrocin. Following a 24-hour incubation period, the picrocrocin IC50 against SK-MEL-2 cells was 20 μM. Apoptosis and cell cycle arrest are the causes of picrocrocin's antiproliferative action. Furthermore, in SK-MEL-2 cells, picrocrocin can lower MMP levels and increase ROS levels. In conclusion, picrocrocin suppresses the SK-MEL-2 melanoma cells' JAK/STAT5 signaling pathway [1]. |
| References |
[1]. Picrocrocin exhibits growth inhibitory effects against SKMEL- 2 human malignant melanoma cells by targeting JAK/ STAT5 signaling pathway, cell cycle arrest and mitochondrial mediated apoptosis. J BUON. 2018 Jul-Aug;23(4):1163-1168. |
| Additional Infomation |
Picrocrocin is a beta-D-glucoside of beta-cyclocitral; the precursor of safranal. It is the compound most responsible for the bitter taste of saffron. It is functionally related to a beta-cyclocitral. Picrocrocin has been reported in Crocus sativus, Crocus tommasinianus, and Crocus vernus with data available. |
Solubility Data
| Solubility (In Vitro) | DMSO : ~100 mg/mL (~302.69 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (7.57 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (7.57 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.5 mg/mL (7.57 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.0269 mL | 15.1345 mL | 30.2691 mL | |
| 5 mM | 0.6054 mL | 3.0269 mL | 6.0538 mL | |
| 10 mM | 0.3027 mL | 1.5135 mL | 3.0269 mL |